Ausgabe 3/2020
Inhalt (21 Artikel)
Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites
Yasuo Hamamoto, Yongzhe Piao, Akitaka Makiyama
Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis
Julie Hallet, Nicole J. Look Hong, Victoria Zuk, Laura E. Davis, Vaibhav Gupta, Craig C. Earle, Nicole Mittmann, Natalie G. Coburn
Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study
Hyo-Joon Yang, Danbee Kang, Yoosoo Chang, Jiin Ahn, Seungho Ryu, Juhee Cho, Eliseo Guallar, Chong Il Sohn
Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO)
Jordan Levy, Vaibhav Gupta, Elmira Amirazodi, Catherine Allen-Ayodabo, Naheed Jivraj, Yunni Jeong, Laura E. Davis, Alyson L. Mahar, Charles De Mestral, Olli Saarela, Natalie Coburn, Jordan Levy, Vaibhav Gupta, Elmira Amirazodi, Catherine Allen-Ayodabo, Naheed Jivraj, Yunni Jeong, Laura E. Davis, James R. Connor, Eugene Hseih, Jolie Ringash, Rinku Sutradhar, Biniam Kidane, Gail E. Darling, Alyson L. Mahar, Natalie G. Coburn
Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer
Tomohiro Kohmoto, Kiyoshi Masuda, Katsutoshi Shoda, Rizu Takahashi, Sae Ujiro, Shoichiro Tange, Daisuke Ichikawa, Eigo Otsuji, Issei Imoto
Utility of the one-step nucleic acid amplification assay in sentinel node mapping for early gastric cancer patients
Ayako Shimada, Hiroya Takeuchi, Tomohiko Nishi, Shuhei Mayanagi, Kazumasa Fukuda, Koichi Suda, Rieko Nakamura, Norihito Wada, Hirofumi Kawakubo, Tadaki Nakahara, Kaori Kameyama, Yuko Kitagawa
JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8
Tadahiko Nakagawa, Yasushi Sato, Toshihito Tanahashi, Yasuhiro Mitsui, Yoshifumi Kida, Yasuteru Fujino, Misato Hirata, Shinji Kitamura, Hiroshi Miyamoto, Koichi Okamoto, Naoki Muguruma, Yoshimi Bando, Tetsuji Takayama
CircDUSP16 promotes the tumorigenesis and invasion of gastric cancer by sponging miR-145-5p
Zizhen Zhang, Chaojie Wang, Yeqian Zhang, Site Yu, Gang Zhao, Jia Xu
LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer
Zhen Yang, Xinhua Dong, Minglong Pu, Hongwei Yang, Weilong Chang, Feihong Ji, Tao Liu, Chongqing Wei, Xiefu Zhang, Xinguang Qiu
Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer
Younghoon Kim, Ye-Young Rhee, Xianyu Wen, Nam-Yun Cho, Jeong Mo Bae, Woo Ho Kim, Gyeong Hoon Kang
Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
Seon-Kyu Kim, Hee-Jin Kim, Jong-Lyul Park, Haejeong Heo, Seon-Young Kim, Sang-Il Lee, Kyu-Sang Song, Woo-Ho Kim, Yong Sung Kim
eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer
Shuting Zhai, Shuang Lin, Zhongjie Lin, Junjie Xu, Tong Ji, Ke Chen, Ke Wu, Hui Liu, Hanning Ying, Weiqiang Fei, Jin Wang, Guoxiang Fu, Yifan Wang, Xiaotong Hu, Xiujun Cai
Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
Li-Tzong Chen, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Hiroki Sameshima, Yoon-Koo Kang, Narikazu Boku
Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
Kazumasa Fujitani, Shigeyuki Tamura, Yutaka Kimura, Jin Matsuyama, Hiroshi Imamura, Kazuyoshi Yamamoto, Junya Fujita, Shohei Iijima, Shugo Ueda, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh
Assessment of lymphatic flow based on the sentinel node concept in early gastric adenocarcinoma that satisfies expanded endoscopic resection criteria
Masashi Takeuchi, Hirofumi Kawakubo, Ayako Shimada, Satoru Matsuda, Tadaki Nakahara, Shuhei Mayanagi, Tomoyuki Irino, Kazumasa Fukuda, Rieko Nakamura, Norihito Wada, Hiroya Takeuchi, Yuko Kitagawa
The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
Ziyu Li, Shuangxi Li, Xiangji Ying, Lianhai Zhang, Fei Shan, Yongning Jia, Jiafu Ji
Adherence with operative standards in the treatment of gastric cancer in the United States
Beiqun Zhao, Sarah L. Blair, Matthew H. G. Katz, Andrew M. Lowy, Kaitlyn J. Kelly
Author’s reply: Stent-in-stent technique resolves late stent obstruction
Yoshio Haga